Grant opportunity preview
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
Offered by National Institutes of Health
HealthcareNationalJanuary 7, 2027
Opportunity summary
The objective of this funding opportunity is to support investigator-initiated, Phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders in adults and children. In addition to supporting clinical…
Sign in to review full eligibility requirements, application details, matching insights, and verified source links.